Chelmow D, Pearlman MD, Young A, Bozzuto L, Dayaratna S, Jeudy M et al (2020) Executive summary of the early-onset breast cancer evidence review conference. Obstet Gynecol 135(6):1457–1478

Article  PubMed  PubMed Central  Google Scholar 

Reyna C, Lee MC (2014) Breast cancer in young women: special considerations in multidisciplinary care. J Multidiscip Healthc 7:419–429

PubMed  PubMed Central  Google Scholar 

Marmolejo DH, Wong MY, Bajalica-Lagercrantz S, Tischkowitz M, Balmaña J, Patócs AB, Chappuis P, Colas C, Genuardi M, Haanpää M, Vetti HH (2021) Overview of hereditary breast and ovarian cancer (HBOC) guidelines across Europe. Eur J Med Genet 64(12):104350

Article  CAS  PubMed  Google Scholar 

Trogdon JG, Ekwueme DU, Chamiec-Case L, Guy GP Jr (2016) Breast cancer in young women: health state utility impacts by race/ethnicity. Am J Prev Med 50(2):262–269

Article  PubMed  PubMed Central  Google Scholar 

Anastasiadi Z, Lianos GD, Ignatiadou E, Harissis HV, Mitsis M (2017) Breast cancer in young women: an overview. Updates Surg 69(3):313–317

Article  PubMed  Google Scholar 

Rosenberg SM, Ruddy KJ, Tamimi RM, Gelber S, Schapira L, Come S et al (2016) BRCA1 and BRCA2 mutation testing in young women with breast cancer. JAMA Oncol 2(6):730–736

Article  PubMed  PubMed Central  Google Scholar 

Kast K, Rhiem K, Wappenschmidt B, Hahnen E, Hauke J, Bluemcke B et al (2016) Prevalence of BRCA1/2 germline mutations in 21 401 families with breast and ovarian cancer. J Med Genet 53(7):465–471

Article  CAS  PubMed  Google Scholar 

Beck AC, Yuan H, Liao J, Imperiale P, Shipley K, Erdahl LM et al (2020) Rate of BRCA mutation in patients tested under NCCN genetic testing criteria. Am J Surg 219(1):145–149

Article  PubMed  Google Scholar 

American society of clinical oncology (ASCO) Knowledge conquers cancer (Cancer.Net®). http://www.cancer.net/cancer-types/hereditary-breast-and-ovarian-cancer (approved by the Cancer.Net Editorial Board, 11/2020). Accessed 20 Aug 2022

Cobain EF, Milliron KJ, Merajver SD (2016) Updates on breast cancer genetics: clinical implications of detecting syndromes of inherited increased susceptibility to breast cancer. Semin Oncol 43(5):528–535

Article  PubMed  Google Scholar 

Wendt C, Margolin S (2019) Identifying breast cancer susceptibility genes–a review of the genetic background in familial breast cancer. Acta Oncol 58(2):135–146

Article  CAS  PubMed  Google Scholar 

Campeau PM, Foulkes WD, Tischkowitz MD (2008) Hereditary breast cancer: new genetic developments, new therapeutic avenues. Hum Genet 124(1):31–42

Article  CAS  PubMed  Google Scholar 

Pashayan N, Antoniou AC, Ivanus U, Esserman LJ, Easton DF, French D et al (2020) Personalized early detection and prevention of breast cancer: ENVISION consensus statement. Nat Rev Clin Oncol 17(11):687–705

Article  PubMed  PubMed Central  Google Scholar 

Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J et al (2015) Standards and guidelines for the interpretation of sequence variants: a joint con- sensus recommendation of the American college of medical genetics and genomics and the association for molecular pathology. Genet Med 17(5):405–424

Article  PubMed  PubMed Central  Google Scholar 

Peshkin BN, Alabek ML, Isaacs C (2010) BRCA1/2 mutations and triple negative breast cancers. Breast Dis 32(1–2):25–33

PubMed  Google Scholar 

Akdeniz Odemis D, Celik B, Kilic Erciyas S, Sukruoglu Erdogan O, Tuncer S, Kurt Gultaslar B et al (2022) Evaluation of BRCA1/2 gene mutations in patients with high-risk breast and/or ovarian cancer in Turkey. Turk J Biochem 47(5):588–594

Article  CAS  Google Scholar 

Biancolella M, Ouédraogo NLM, Zongo N, Zohoncon TM, Testa B, Rizzacasa B et al (2021) Breast cancer in West Africa: molecular analysis of BRCA genes in early-onset breast cancer patients in Burkina Faso. Hum Genomics 15(1):65

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yildiz Tacar S, Bozgeyik E, Seber ES, Yetisyigit T, Tozkir H, Avci O et al (2020) Next generation sequencing analysis of BRCA1 and BRCA2 identifies novel variations in breast cancer. Life Sci 261:118334

Article  CAS  PubMed  Google Scholar 

Guidugli L, Shimelis H, Masica DL, Pankratz VS, Lipton GB, Singh N et al (2018) Assessment of the clinical relevance of BRCA2 missense variants by functional and computational approaches. Am J Hum Genet 102(2):233–248

Article  CAS  PubMed  PubMed Central  Google Scholar 

Richardson ME, Hu C, Lee KY, LaDuca H, Fulk K, Durda KM et al (2021) Strong functional data for pathogenicity or neutrality classify BRCA2 DNA-binding-domain variants of uncertain significance. Am J Hum Genet 108:458–468

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mesman RLS, Calléja F, Hendriks G, Morolli B, Misovic B, Devilee P et al (2019) The functional impact of variants of uncertain significance in BRCA2. Genet Med 21(2):293–302

Article  CAS  PubMed  Google Scholar 

Ikegami M, Kohsaka S, Ueno T, Momozawa Y, Inoue S, Tamura K et al (2020) High-throughput functional evaluation of BRCA2 variants of unknown significance. Nat Commun 11(1):2573

Article  CAS  PubMed  PubMed Central  Google Scholar 

Biswas K, Lipton GB, Stauffer S, Sullivan T, Cleveland L, Southon E et al (2020) A computational model for classification of BRCA2 variants using mouse embryonic stem cell-based functional assays. NPJ Genom Med 5(1):52

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hu C, Susswein LR, Roberts ME, Yang H, Marshall ML, Hiraki S et al (2022) Classification of BRCA2 variants of uncertain significance (VUS) using an ACMG/AMP model incorporating a homology-directed repair (HDR) functional assay. Clin Cancer Res 28(17):3742–3751

Article  CAS  PubMed  PubMed Central  Google Scholar 

Frank TS, Deffenbaugh AM, Reid JE, Hulick M, Ward BE, Lingenfelter B et al (2002) Clinical characteristics of individuals with germline mutations in BRCA1 and BRCA2: analysis of 10,000 individuals. J Clin Oncol 20(6):1480–1490

Article  CAS  PubMed  Google Scholar 

Eggington JM, Bowles KR, Moyes K, Manley S, Esterling L, Sizemore S et al (2014) A comprehensive laboratory-based program for classification of variants of uncertain significance in hereditary cancer genes. Clin Genet 86(3):229–237

Article  CAS  PubMed  Google Scholar 

Ferla R, Calò V, Cascio S, Rinaldi G, Badalamenti G, Carreca I et al (2007) Founder mutations in BRCA1 and BRCA2 genes. Ann Oncol 18(Suppl. 6):vi93-98

Article  PubMed  Google Scholar 

Janavičius R (2010) Founder BRCA1/2 mutations in the Europe: implications for hereditary breast-ovarian cancer prevention and control. EPMA J 1(3):397–412

Article  PubMed  PubMed Central  Google Scholar 

Møller P, Heimdal K, Apold J, Fredriksen A, Borg A, Hovig E et al (2001) Genetic epidemiology of BRCA1 mutations in Norway. Eur J Cancer 37(18):2428–2434

Article  PubMed  Google Scholar 

King MC, Marks JH, Mandell JB (2003) Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2. Science 302(5645):643–6

Article  CAS  PubMed  Google Scholar 

Bahsi T, Erdem HB (2019) Spectrum of BRCA1/BRCA2 variants in 1419 Turkish breast and ovarian cancer patients: a single center study. Turk J Biochem 45(1):83–90

Article  Google Scholar 

Gezdirici A, Gökpınar İli E, Değirmenci B, Gümüş AA, Özdemir G, Erman NA, et al (2021) Hereditary breast-ovarian cancer and BRCA1/BRCA2 variants: a single center experience. Acta Oncol Tur 54(3):264–272

Article  Google Scholar 

Cecener G, Takanlou LB, Takanlou MS, Egeli U, Eskiler GG, Aksoy S et al (2020) Clinicopathologic features and genetic characteristics of the BRCA1/2 mutation in Turkish breast cancer patients. Cancer Genet 240:23–32

Article  CAS  PubMed  Google Scholar 

Yazici H, Bitisik O, Akisik E, Cabioglu N, Saip P, Muslumanoglu M et al (2000) BRCA1 and BRCA2 mutations in Turkish breast/ovarian families and young breast cancer patients. Br J Cancer 83(6):737–742

Article  CAS  PubMed  PubMed Central  Google Scholar 

Demir S, Tozkir H, Gurkan H, Atli EI, Yalcintepe S, Atli E et al (2020) Genetic screening results of individuals with high risk BRCA-related breast/ovarian cancer in Trakya region of Turkey. J BUON 25(3):1337–1347

PubMed  Google Scholar 

Hogervorst FB, Nederlof PM, Gille JJ, McElgunn CJ, Grippeling M, Pruntel R et al (2003) Large genomic deletions and duplications in the BRCA1 gene identified by a novel quantitative method. Cancer Res 63(7):1449–1453

CAS  PubMed  Google Scholar 

Montagna M, Dalla Palma M, Menin C, Agata S, De Nicolo A, Chieco-Bianchi L et al (2003) Genomic rearrangements account for more than one-third of the BRCA1 mutations in northern Italian breast/ovarian cancer families. Hum Mol Genet 12(9):1055–1061

Article  CAS  PubMed